CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on: April 12,2024

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on:April 12,2024

Breast cancer findings 'suggest a new set of criteria for avoiding radiation'

by Maureen Salamon,Harvard Medical SchoolCredit: Unsplash/CC0 Public DomainWomen diagnosed with early-stage breast cancer often can choose to have a lumpectomy, which removes only cancerous tiss

Updated on: January 03,2024

Breast cancer findings 'suggest a new set of criteria for avoiding radiation'

by Maureen Salamon,Harvard Medical SchoolCredit: Unsplash/CC0 Public DomainWomen diagnosed with early-stage breast cancer often can choose to have a lumpectomy, which removes only cancerous tiss

Updated on:January 03,2024

Study reveals mechanism linking heart disease to cancer development

byTel-Aviv UniversityCredit: CC0 Public DomainResearchers at Tel Aviv University (TAU) and the Leviev Cardiothoracic and Vascular Center at the Sheba Medical Center have found a mechanism respon

Updated on: April 28,2024

Study reveals mechanism linking heart disease to cancer development

byTel-Aviv UniversityCredit: CC0 Public DomainResearchers at Tel Aviv University (TAU) and the Leviev Cardiothoracic and Vascular Center at the Sheba Medical Center have found a mechanism respon

Updated on:April 28,2024

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on: May 23,2024

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on:May 23,2024

Researchers reveal why vaccines have lower efficacy in patients with multiple myeloma

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researc

Updated on: August 28,2024

Researchers reveal why vaccines have lower efficacy in patients with multiple myeloma

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researc

Updated on:August 28,2024

Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

by Ochsner Health SystemAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA research study recently published in theAmerican Journal of G

Updated on: March 30,2024

Exploring the impact of pancreatic enzyme therapy in pediatric pancreatitis: A leap toward personalized medicine

by Ochsner Health SystemAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA research study recently published in theAmerican Journal of G

Updated on:March 30,2024

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer

Updated on: March 12,2024

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer

Updated on:March 12,2024

Vitamin A may reduce pancreatitis risk during ALL treatment

by Cincinnati Children's Hospital Medical CenterStudy inScience Translational Medicineshows potential benefit of vitamin A treatment to reduce side effect risks during treatment f

Updated on: February 01,2024

Vitamin A may reduce pancreatitis risk during ALL treatment

by Cincinnati Children's Hospital Medical CenterStudy inScience Translational Medicineshows potential benefit of vitamin A treatment to reduce side effect risks during treatment f

Updated on:February 01,2024

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

Updated on: September 25,2024

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

Updated on:September 25,2024

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

by Brandon Chase,Massachusetts General HospitalA molecule called MHC-II (seen here in green) disguises metastatic breast cancer cells (red), allowing them to invade the lymph nodes and take root

Updated on: February 18,2024

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

by Brandon Chase,Massachusetts General HospitalA molecule called MHC-II (seen here in green) disguises metastatic breast cancer cells (red), allowing them to invade the lymph nodes and take root

Updated on:February 18,2024

Newly developed PSG score improves patient selection for PSMA radiopharmaceutical therapy

by Society of Nuclear Medicine and Molecular ImagingRepresentative PET images of 6 patients classified as having high, intermediate, and low visual PSG scores. Credit: Society of Nuclear Medicine and

Updated on: January 13,2024

Newly developed PSG score improves patient selection for PSMA radiopharmaceutical therapy

by Society of Nuclear Medicine and Molecular ImagingRepresentative PET images of 6 patients classified as having high, intermediate, and low visual PSG scores. Credit: Society of Nuclear Medicine and

Updated on:January 13,2024

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Updated on: March 30,2024

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Updated on:March 30,2024